| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |